Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ViTaL02: A study of a new vaccine against Lassa
PACTR202506787993203Phase 1Not yet recruiting
- Sponsor
- University of Oxford
- Start
- Oct 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1 trial of ChAdOx1 LassaJ in Lassa fever (2 arms), sponsored by University of Oxford. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
ChAdOx1 LassaJ
03
Conditions
Lassa fever
Beyond the preview
Go deeper on PACTR202506787993203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202506787993203.